--News Direct--
By Johnny Rice, Benzinga
Leonard Mazur, CEO and founder of Citius Pharmaceuticals (NASDAQ: CTXR), was recently interviewed by Benzinga.
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, stem cell therapy, and unique prescription products.
Mazur spoke about the exciting developments in the company’s assets, including the imminent launch of its first drug on the market.
Learn more here:
Featured photo by freestocks on Unsplash.
Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
Contact Details
Benzinga
+1 877-440-9464
Company Website
View source version on newsdirect.com: https://newsdirect.com/news/this-pharma-company-is-preparing-to-launch-its-lead-candidate-252698575
